Psg19 inhibitors are a class of chemical compounds that specifically target the activity of the protein Psg19, a member of the pregnancy-specific glycoprotein (PSG) family. The PSG proteins are part of the carcinoembryonic antigen (CEA) family, a subset of the immunoglobulin superfamily, and play various roles in cellular communication and signaling. The inhibition of Psg19 is achieved through a variety of structural motifs within these inhibitors, which allow them to bind with high specificity to Psg19 and block its activity. These compounds often exhibit diverse chemical backbones, such as small molecule scaffolds, peptides, or even larger macromolecular inhibitors, depending on the nature of the interaction required to achieve selective inhibition. The chemical design of Psg19 inhibitors is often guided by the structural characteristics of Psg19, including the protein's binding domains and three-dimensional conformation, ensuring that the inhibitors can achieve an effective binding affinity and specificity.
These inhibitors work by interfering with Psg19's ability to interact with its natural ligands or other molecular targets, disrupting signaling pathways in which Psg19 plays a key role. The structural diversity of Psg19 inhibitors allows for the fine-tuning of binding properties, such as solubility, stability, and affinity. The development of these inhibitors often involves an in-depth understanding of the structure-activity relationship (SAR) of Psg19 and its ligands, allowing researchers to optimize the potency and selectivity of these compounds. Structural modifications to the core scaffold, functional group alterations, and exploration of conformational isomers are common strategies employed to enhance their binding efficiency. While Psg19 inhibitors have been primarily studied in the context of molecular biology and biochemistry to elucidate the functions and pathways involving Psg19, their development represents a growing interest in understanding the intricate roles of PSG family proteins in cellular signaling and regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is a natural polyphenol that may inhibit PSGB1 expression by modulating transcription factors or signaling pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a component of turmeric, has been suggested to inhibit PSGB1 expression by affecting gene transcription or protein stability. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine may inhibit PSGB1 expression through modulation of cellular signaling pathways or transcriptional regulators. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin, a flavonoid, may potentially inhibit PSGB1 expression by modulating gene transcription or protein stability. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a catechin found in green tea, has been suggested to inhibit PSGB1 expression by affecting cellular signaling pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein may inhibit PSGB1 expression by modulating transcription factors or signaling pathways involved in gene expression. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin, a flavonoid, may potentially inhibit PSGB1 expression by affecting gene transcription or protein stability. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
Apigenin may inhibit PSGB1 expression by modulating cellular signaling pathways or transcriptional regulators. | ||||||
Piperine | 94-62-2 | sc-205809 sc-205809A | 5 g 25 g | $37.00 $146.00 | 3 | |
Piperine may inhibit PSGB1 expression through modulation of cellular signaling pathways or transcriptional regulators. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane may inhibit PSGB1 expression by affecting gene transcription or protein stability. | ||||||